This Week's Upcoming IPO Calendar Led by EQGP and FTAI

upcoming ipo calendar

upcoming ipo calendarThere are nine deals on this week's upcoming IPO calendar. They're expected to raise a combined $1.4 billion.

Last week saw the largest IPO of 2015. Tallgrass Energy GP LP (NYSE: TEGP) took the year's top spot by raising $1.2 billion, surpassing Columbia Pipeline Partners LP's (NYSE: CPPL) $1.1 billion.

Bojangles' Inc. (Nasdaq: BOJA) continued the restaurant IPO hot streak last week, pricing at the high end of its range and gaining 25% in its debut. That was the first restaurant IPO since Shake Shack Inc. (NYSE: SHAK), which gained 119% in its debut on Jan. 29.

While TEGP was the largest by deal size, this week will see the largest IPO by market cap so far this year...

EQT GP Holdings LP's (NYSE: EQGP) $6 billion valuation makes it the year's largest company to go public. The Pittsburgh-based master limited partnership (MLP) owns interests in EQT Midstream Partners LP (NYSE: EQM). EQGP was formed last year and posted $523 million in sales from March 2014 to March 2015.

According to Renaissance Capital, a manager of IPO-focused ETFs, the MLP is set for a $450 million deal by selling 20 million shares at a $21 to $24 price range. EQGP stock will begin trading on Tuesday, May 12.

Here are the eight other deals this week on the upcoming IPO calendar...

This Week's Upcoming IPO Calendar

Fortress Transportation and Infrastructure Investors LLC (NYSE: FTAI) is a limited liability company (LLC) formed by Fortress Investment Group LLC (NYSE: FIG). FTAI owns an array of high-yielding transportation assets in aviation, shipping, and offshore energy. These include airplanes, jet engines, shipping containers, railway lines, and intermodal equipment. The New York-based company raked in $58 million in sales last year. It plans to raise $400 million by offering 20 million shares at a price range of $19 to $21. FTAI is valued at $1.5 billion and will hit the market on Thursday, May 14.

Money Morning Members: Keep reading for the rest of this week's upcoming IPO calendar, including the year's largest biotech. For those new to Money Morning, sign up to keep reading - it's completely free...

[epom key="ddec3ef33420ef7c9964a4695c349764" redirect="" sourceid="" imported="false"]Galapagos NV (Nasdaq: GLPG) is developing new treatments for inflammatory diseases. Its most advanced candidate drug treats patients with rheumatoid arthritis. Johnson & Johnson (NYSE: JNJ) and AbbVie Inc. (NYSE: ABBV) will invest $55 million in the IPO. The Belgian company is currently listed on the Euronext Brussels and Euronext Amsterdam. It's up over 50% since filing its U.S. listing on April 15. Galapagos will raise $200 million by selling 4.72 million shares for $42.43. Its $1.6 billion valuation makes it the largest biotech of the year by market cap. GLPG stock will debut on Thursday, May 14.

Fenix Parts Inc. (Nasdaq: FENX) is a newly formed rollup-merger of auto parts manufacturers. Founded in January 2014, Fenix combined eight companies to create a network offering sales and distribution in the U.S. and Canada. The company mostly focuses on recycling and reselling original manufacturing equipment for automotive products. Fellow auto parts firm LKQ Corp. (Nasdaq: LKQ) is down 2.2% this year. Fenix hopes to raise $110 million by offering 11 million shares at a price range of $9 to $11. The company commands a $166 million valuation and will begin trading on Thursday, May 14.

Arcadia Biosciences Inc. (Nasdaq: RKDA) is set for a $100 million deal by selling 7.15 million shares at a $13 to $15 price range. The crop productivity trait developer will hit the market on Wednesday, May 13.

MultiVir Inc. (Nasdaq: MVIR) will raise $60 million by offering 4.6 million shares at a price range of $12 to $14. The cancer-treatment biotech was delayed last week and is expected to debut sometime this week.

Gelesis Inc. (Nasdaq: GLSS) is expected to raise $52 million by selling 4 million shares at a $12 to $14 price range. The weight-loss pill maker delayed its pricing last week and is expected to price this week.

Anterios Inc. (Nasdaq: ANTE) is set for a $51 million deal by offering 3.9 million shares at a price range of $12 to $14. The botox biotech was supposed to hit the market last week but has been pushed back to this week.

Jaguar Animal Health Inc. (Nasdaq: JAGX) hopes to raise $22 million by selling 3.15 million shares for $7. The animal diarrhea treatment company will begin trading on Wednesday, May 13.

Thoughts on this week's upcoming IPO calendar? Talk to us on Twitter at @AlexMcGuire92 and @moneymorning.

Bonus Content: Tom Gentile has been named "America's #1 Trader" for more than a decade now. That's because he's taught over 300,000 people how to build wealth through simple trading techniques. Here's how to get his free report - including a double-digit profit move you can make today...

Recommended